Literature DB >> 19105779

The implantable cardioverter defibrillator: its history, current psychological impact and future.

Melissa Matchett1, Samuel F Sears, Garrett Hazelton, Kari Kirian, Elynor Wilson, Rajasekhar Nekkanti.   

Abstract

The innovation of the implantable cardioverter defibrillator (ICD) represents a modern medical achievement with substantial life-saving benefits for patients at risk for potentially life-threatening arrhythmias. Over a decade of research resulted in the first ICD implantation in 1980, dramatically changing the face of cardiac care. The introduction of the device was met by skepticism and outright rejection by some, yet large-scale clinical trials clearly demonstrated the mortality benefit of the ICD. Today, specific challenges for this technology have emerged, including barriers to individual and social acceptance of the ICD as a viable form of technology, as well as psychosocial adjustment difficulties and fears in patients. To address these challenges, scientific research, improved communication regarding devices and psychosocial interventions have been developed and extended to this patient population. As such, it is hypothesized that the future will hold expanding indications for ICD implantation, while further meeting patients' medical and psychosocial adjustment needs. The purposes of this paper are to review the history of ICD innovation, describe past and present research on psychosocial adjustment to the ICD, and corresponding psychosocial interventions, analyze individual and social acceptance and utilization of device technology, and forecast future applications and developments of the ICD.

Entities:  

Mesh:

Year:  2009        PMID: 19105779     DOI: 10.1586/17434440.6.1.43

Source DB:  PubMed          Journal:  Expert Rev Med Devices        ISSN: 1743-4440            Impact factor:   3.166


  6 in total

1.  [Psychological comorbidity and quality of life in patients with an implantable cardioverter/defribrillator (ICD)].

Authors:  K-H Ladwig; J Ronel; J Baumert; C Kolb
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2010-06

2.  Time-Dependent Changes in Psychosocial Distress in Japanese Patients with Implantable Cardioverter Defibrillators.

Authors:  Nao Saito; Chiemi Taru; Ikuko Miyawaki
Journal:  Kobe J Med Sci       Date:  2016-12-02

3.  Cardiac sympathetic denervation and mental health.

Authors:  Sahib S Khalsa; Ashley N Clausen; Leila Shahabi; Julie Sorg; Sarah E Gonzalez; Bruce Naliboff; Kalyanam Shivkumar; Olujimi A Ajijola
Journal:  Auton Neurosci       Date:  2021-02-14       Impact factor: 3.145

4.  Psychosocial Stress Hastens Disease Progression and Sudden Death in Mice with Arrhythmogenic Cardiomyopathy.

Authors:  Jacopo Agrimi; Arianna Scalco; Julia Agafonova; Larry Williams Iii; Nainika Pansari; Gizem Keceli; Seungho Jun; Nadan Wang; Francesca Mastorci; Crystal Tichnell; Brittney Murray; Cynthia A James; Hugh Calkins; Tania Zaglia; Nazareno Paolocci; Stephen P Chelko
Journal:  J Clin Med       Date:  2020-11-24       Impact factor: 4.241

5.  Rationale and design of WEBCARE: a randomized, controlled, web-based behavioral intervention trial in cardioverter-defibrillator patients to reduce anxiety and device concerns and enhance quality of life.

Authors:  Susanne S Pedersen; Viola Spek; Dominic A M J Theuns; Marco Alings; Pepijn van der Voort; Luc Jordaens; Pim Cuijpers; Johan Denollet; Krista C van den Broek
Journal:  Trials       Date:  2009-12-23       Impact factor: 2.279

6.  Assessment of the quality of existing patient educational tools focused on sudden cardiac arrest: a systematic evaluation by the Sudden Cardiac Arrest Thought Leadership Alliance.

Authors:  Garrett Hazelton; Sana M Al-Khatib; Gregg C Fonarow; Kevin L Thomas; David Hayes; Gillian D Sanders; Susan M Campbell; Clyde Yancy; Eric D Peterson; Samuel Sears
Journal:  Patient Prefer Adherence       Date:  2013-04-26       Impact factor: 2.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.